Analysis and mining of L-ornithine L-aspartate adverse events based on FAERS database

Abstract L-ornithine L-aspartate (LOLA) is indicated for reducing blood ammonia levels and alleviating symptoms of hepatobiliary disorders. Data mining of adverse events associated with LOLA was carried out in the FDA Adverse Event Reporting System database. The aim was to explore its potential medi...

詳細記述

書誌詳細

出版年:	Scientific Reports
主要な著者:	Hui Zhang, Chaoqun Song, Dexi Zhao, Minghao Lin, Yujuan Fu
フォーマット:	論文
言語:	英語
出版事項:	Nature Portfolio 2025-07-01
主題:	LOLA FAERS Hepatobiliary disorders
オンライン･アクセス:	https://doi.org/10.1038/s41598-025-12420-w